DrugBank

AUGUST 15, 2024

Drug development is challenging, including not only the complexities of biomolecular drug mechanisms but also the convolutions of regulatory pathways and commercialization strategies. Improved Return on Investment (ROI) Industry-academic partnerships can enhance the financial return on drug development investments.

Drug Development 81

Drug Development Clinical Trials Drugs Therapies 81

Conversations in Drug Development Trends

AUGUST 10, 2023

With so many exciting developments in the last few years, it’s critical for the psychedelic community to come together to reflect on our progress, share the latest discoveries, and discuss the future of psychedelic research. The post 3 Key Takeaways from Psychedelic Science 2023 appeared first on Worldwide Clinical Trials.

Science 98

Science Clinical Trials Trials Clinical Research 98

LifeSciVC

JANUARY 3, 2024

This is an exciting development both for HotSpot and for the field – not only has the CBM complex been successfully targeted in vitro and in vivo for the first time, but we believe we now have a roadmap for drugging other signaling assemblies relevant to disease.

Drug Development 89

Drug Development Drugs Small Molecule Disease 89

Drug Target Review

JULY 18, 2023

Artificial Intelligence (AI) is poised to transform the field of target discovery in drug development, offering immense potential to enhance efficacy, personalised medicine, and accelerate the development of innovative compounds. Cavlan explains that “they are brilliant at developing and bringing new drugs to market.”

Drug Development 98

Drug Development Drugs Clinical Development Pharmaceutical Companies 98

FDA Law Blog: Biosimilars

JUNE 27, 2023

James was only one of five life sciences attorneys selected and the only food and drug lawyer to make the list. Amongst his accomplishments, Law360 considered the role James has played in leveraging little-used pathways to FDA approval for often first-ever drugs to treat rare diseases (e.g., Valentine , as a 2023 Rising Star.

Science 81

Science FDA Approval FDA Drug Development 81

Drug Patent Watch

DECEMBER 10, 2024

Generic drug development is a complex process that involves not only scientific and medical expertise but also adherence to strict legal and ethical standards. Scientific expertise plays a crucial role in ensuring that generic drugs are held to the same standards of quality, safety, and efficacy as their brand-name counterparts.

Drug Development 52

Drug Development Pharmacokinetics Compliance Drugs 52

Drug Patent Watch

DECEMBER 10, 2024

Generic drug development is a complex process that requires a deep understanding of regulatory requirements and guidelines. Regulatory expertise plays a crucial role in ensuring that generic drugs meet the necessary standards for quality, safety, and efficacy. ” Scientific Research Publishing , 2024. ” U.S.

Drug Development 52

Drug Development Compliance Drugs Regulations 52

Drug Target Review

AUGUST 7, 2024

The pharmaceutical industry is undergoing a major shift towards the development of breakthrough medicines and advanced therapies. This continued innovation highlights the complexity of the drug development process, particularly as the field is highly regulated by health authorities around the world.

Drug Development 59

Drug Development Clinical Pharmacology Clinical Trials Packaging 59

Fierce BioTech

APRIL 4, 2024

Discover how leading organizations leverage AI to revolutionize operations and expedite drug development, ensuring faster access to life-saving treatments. Gain insights into successful case studies and strategies for leveraging AI in life science innovation. Click here to login. Listing Image Appian-LogoListing-9142023.png

Science 52

Science Compliance Drug Development Treatment 52

LifeSciVC

FEBRUARY 27, 2024

By Ivana Magovčević-Liebisch, CEO of Vigil Neuroscience, as part of the From The Trenches feature of LifeSciVC Patients and their care partners are at the center of our work in the life sciences industry – but at what point during the drug development process should companies start to engage these key stakeholders?

Drug Development 60

Drug Development Disease Drugs Treatment 60

Alta Sciences

APRIL 17, 2024

Five Promising Treatment Areas in Early-Phase Drug Development in 2024 aasimakopoulos Wed, 04/17/2024 - 15:52 Early-phase drug development is an ever-changing landscape, as emerging science leads to new promising areas of research for the treatment of human health issues.

Drug Development 52

Drug Development Treatment FDA Approval Therapies 52

SCIENMAG: Medicine & Health

JUNE 14, 2023

Although effective drugs and therapies have been developed for most breast cancer subtypes, triple negative breast cancer lacks the key receptors that these drugs interact with – in other words, it’s negative for the three receptors for which […]

Drug Development 87

Drug Development Drugs Therapies Science 87

Drug Target Review

AUGUST 9, 2024

The science behind drug formulation The formulation of a drug is both an art and a science, requiring a deep understanding of the drug’s chemical and physical properties. 1 Challenges in drug formulation Developing a successful drug formulation is fraught with challenges.

Science 59

Science Drugs Compliance Drug Development 59

H1 Blog

OCTOBER 30, 2023

The application of AI in the life sciences sector has the potential to revolutionize many aspects of research, development, and patient care. Here are 4 predictions for how life sciences companies might be using AI by then. Drug Repurposing AI can analyze existing drugs and their effects to find new therapeutic applications.

Science 59

Science Clinical Trials Trials Engineering 59

Drug Target Review

OCTOBER 14, 2024

Wilkie’s background as a biochemist and his time at Merck, a leading pharmaceutical company, shaped his early understanding of drug development and business strategy. As someone who describes himself as an “enthusiastic sceptic,” Wilkie is cautious but hopeful about the potential of AI in drug development. “I

Science 52

Science Pharmaceutical Companies Drug Development Pharmaceuticals 52

Perficient: Drug Development

SEPTEMBER 22, 2023

With a highly skilled team of Salesforce consultants and developers with Healthcare and Life Sciences (HLS) experience, Perficient is especially interested in this year’s announcements for the vertical. Here are takeaways for Salesforce clients, consultants, and developers working in HLS.

Science 59

Science Clinical Trials Engineering Production 59

Drug Target Review

AUGUST 28, 2024

Most recently Dr Brass was Vice President, Head of Clinical Sciences for Hepatology, Gastroenterology and Transplantation in Global Drug Development at Novartis. He is named on 15 patents relating to drug development in liver disease.

Therapies 114

Therapies Disease Engineering Medical Schools 114

Perficient: Drug Development

JANUARY 16, 2024

I’ve spent essentially my entire career in the medical device and life science space, and it didn’t start the way you would think. With all this in mind, here are three ways medical device and life science companies can leverage Adobe Commerce to build solutions that help everyone within the healthcare lifecycle.

Science 52

Science Nurses Production Pharmacy 52

Perficient: Drug Development

JUNE 26, 2024

Brand activism is a new buzzword in healthcare and life sciences spaces, and consumers are increasingly expecting their brands of choice to drive social change. So let’s talk about what brand advocacy looks like in healthcare and life sciences and how organizations can begin to build greater advocacy into their plans. The best part?

Science 52

Science Production International Research 52

Perficient: Drug Development

MARCH 14, 2024

So how can healthcare and life sciences organizations capitalize on this opportunity? Lunch and Networking: Dine and connect with healthcare and life sciences industry peers who share your passion for digital excellence before heading off for afternoon sessions at Adobe Summit. . What to Expect 11:30 A.M.

Science 52

Science Pharmacy Marketing Production 52

DrugBaron

JANUARY 31, 2024

After decades slowly developing in the shadows, featuring more often in science fiction novels than television news programs, the arrival of large language models, and ChatGPT in particular, thrust artificial intelligence into the national consciousness. Does AI improve decision making in drug R&D?

Pharma R&D 165

Pharma R&D Science Small Molecule Drugs 165

Drug Target Review

DECEMBER 9, 2024

Baker’s model could revolutionise drug development, synthetic biology, and nanotechnology, opening possibilities for new medical treatments, vaccines, nanomaterials, and sensors. Presumably, some of these compositions include proteins synthesised using Bakers AI model.

Engineering 105

Engineering International Drug Development Science 105

Drug Target Review

SEPTEMBER 22, 2023

5 Organoids are recognised as New Alternative Methods (NAMs) in drug development. This recognition was codified by the United States Food and Drug Administration (FDA) in 2022 with the signing of the FDA Modernisation Act 2.0 This can aid in the development of safer, more effective therapeutic strategies.

Clinical Research 116

Clinical Research Research Drug Development Molecular Biology 116

Drug Target Review

SEPTEMBER 5, 2024

However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company. Kristina is a pharmacist and holds a PhD in Medical Science from Linköping University.

Pharma Companies 111

Pharma Companies Licensing Licensing Disease 111

Perficient: Drug Development

SEPTEMBER 10, 2024

The healthcare and life sciences industries are rapidly evolving, fueled by the demand for innovation, efficiency, and patient-centric care. Powering Patient-Centric Clinical Trials with AI and Data Explore how Life Sciences Cloud leverages AI to power comprehensive, customized, next-generation clinical trials for pharmaceutical companies.

Science 52

Science Clinical Trials Pharmaceutical Companies Trials 52

Drug Patent Watch

DECEMBER 9, 2024

In the vast realm of pharmaceutical research and development, there’s a fascinating intersection between ancient wisdom and modern science. This intersection is where pharmacognosy meets drug patents, creating a unique landscape that shapes the future of medicine.

Drugs 87

Drugs Drug Development Pharmaceuticals Production 87

Alta Sciences

MARCH 27, 2024

Up Close and Personal With Eryn Corriveau, MSc, Senior Director, Drug Development and Regulatory Strategy nbartlett Wed, 03/27/2024 - 20:21 Here at Altasciences, Eryn is responsible for guiding regulatory strategies , conducting gap analyses, and leading interactions with regulatory agencies dur ing early drug development.

Drug Development 52

Drug Development Medical Schools Pharma Companies Drugs 52

PPD

JULY 29, 2024

Artificial Intelligence (AI) imitates human cognitive functions using computer science, algorithms, machine learning and data sciences. AI can analyze large volumes of data from interventional and non-interventional studies to draw conclusions about a drug’s safety and effectiveness quicker than humans.

Clinical Research 98

Clinical Research Clinical Trials Research Trials 98

Drug Target Review

FEBRUARY 19, 2024

I always found science fascinating, but I really fell in love with it in high school when I was introduced to biochemistry and molecular biology. It was then that I knew I wanted to dedicate my career to science. If you are passionate about science and technology GO FOR IT! BECOME A ROLE MODEL! BECOME A ROLE MODEL!

Molecular Biology 110

Molecular Biology Science Protein Expression Production 110

Perficient: Drug Development

OCTOBER 2, 2023

The 3-day conference promises to explore what Optimizely calls “the intersection of art and science.” Optimizely’s Opticon 2023 begins next week on Tuesday, October 10 in sunny San Diego.

Science 59

Science Production 59

SCIENMAG: Medicine & Health

OCTOBER 31, 2023

— A new drug developed by professors from the School of Pharmacy and Pharmaceutical Sciences at Binghamton University has received Food and Drug Administration (FDA) approval for the treatment of patients with Duchenne muscular dystrophy (DMD), a common genetic disease that mostly affects young boys.

FDA Approval 83

FDA Approval FDA Disease Pharmacy 83

Perficient: Drug Development

NOVEMBER 13, 2023

In our previous article , we illuminated the significance of business transformation for life sciences and healthcare organizations (LS/HCOs). Business transformation is not a fleeting trend—it’s an essential strategy for organizations to remain competitive in a constantly evolving healthcare and life sciences industry.

Science 52

Science Government Regulations FDA 52

Conversations in Drug Development Trends

DECEMBER 7, 2023

Despite a rapidly evolving clinical development landscape, we’ve remained grounded in medicine and science, helping sponsors achieve their clinical development goals across a range of therapeutic areas through our ability to adapt to changing client needs, deliver customized study teams, and dedicated scientific expertise.

Clinical Trials 136

Clinical Trials Clinical Development Trials Pharmaceutical Companies 136

thought leadership

JULY 16, 2024

The key to successful drug development in the US is directional and focused navigation of FDA’s Investigational New Drug (IND) process. The data provided in the CMC sections within Module 3 of an IND application provide FDA with information on the drug’s:

Drug Development 40

Drug Development FDA Drugs Science 40

BMG Labtech

MARCH 11, 2024

Enzyme-Linked Immunosorbent Assays (ELISAs) are an essential technique in today’s laboratory with many applications in the life sciences. They are often the method of choice to detect or measure specific biological molecules (analytes) for diagnostics, drug discovery or fundamental research.

Vaccine 98

Vaccine Molecular Biology Laboratories Virus 98

thought leadership

DECEMBER 18, 2024

On November 27,2024, FDA released a draft guidance intended to inform industry and the review staff in the Center for Drug Evaluation and Research (CDER) on how CDER views positive findings in the in vitro bacterial reverse mutation (Ames) test of a drug (active ingredient) or its metabolites and to provide recommendations on follow-up in vitro and (..)

FDA 52

FDA Drug Development Clinical Trials Drugs 52

Perficient: Drug Development

MARCH 20, 2024

In our latest podcast episode, Jim talks with Kristine Swan , the VP of Digital Transformation and IT at Bayer Crop Science , for a conversation that’s as rich and fertile as the soil our future depends on. Kristine brings a personal touch to the digital revolution in agriculture, drawing on her roots on a Missouri farm.

Science 105

Science Production Marketing 105